Quarfloxin

DRUG2 trials

Sponsors

Cylene Pharmaceuticals

Conditions

Advanced Solid TumorsCarcinoid TumorLymphomaNeuroendocrine Tumors

Phase 1

Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas

TerminatedNCT00955292

Cylene PharmaceuticalsAdvanced Solid Tumors, Lymphoma

Start: 2007-07-31End: 2008-12-31Updated: 2009-08-10

Phase 2

Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma

CompletedNCT00780663

Cylene PharmaceuticalsCarcinoid Tumor, Neuroendocrine Tumors

Start: 2008-10-31End: 2010-03-31Target: 25Updated: 2011-06-15